Form 4: Acurx Pharmaceuticals Director Thomas Harrison Acquires 12,000 Stock Options

Director Thomas Harrison acquired 12,000 stock options in Acurx Pharmaceuticals on June 17, 2024, related to his board service.

Summary

• Thomas Harrison, a director of Acurx Pharmaceuticals, acquired 12,000 stock options on June 17, 2024.
• The options were granted as part of the Issuer's Director Compensation Policy for service on the board.
• The exercise price of the stock options is $2.38.
• The options vest on June 17, 2025, and expire on June 17, 2034.
• Following the transaction, Harrison directly owns 12,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction. The acquisition of stock options by a director is generally viewed as a positive, but it's a routine event.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The acquisition of stock options by a director could have a minor positive impact on shareholder sentiment, as it may signal confidence in the company's future.

Key Dates